Neuren Pharmaceuticals Limited's market cap is currently ―. The company's EPS TTM is $0.815; its P/E ratio is 15.29; Neuren Pharmaceuticals Limited is scheduled to report earnings on August 27, 2024, and the estimated EPS forecast is $0.13. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 40.18M	AU$ 36.78M	AU$ 24.19M	AU$ 13.84M	AU$ 23.58M
Total Assets	AU$ 43.27M	AU$ 40.06M	AU$ 24.95M	AU$ 14.41M	AU$ 26.64M
Total Debt	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -40.18M	AU$ -36.78M	AU$ -24.19M	AU$ -13.84M	AU$ -23.58M
Total Liabilities	AU$ 1.68M	AU$ 803.00K	AU$ 753.00K	AU$ 559.00K	AU$ 1.97M
Stockholders Equity	AU$ 41.59M	AU$ 39.25M	AU$ 24.20M	AU$ 13.85M	AU$ 24.67M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Neuren Pharmaceuticals Limited Earnings and Revenue History

Income Statement >

Neuren Pharmaceuticals Limited Debt to Assets

Balance Sheet >

Neuren Pharmaceuticals Limited Cash Flow

Cash Flow >

Neuren Pharmaceuticals Limited Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing